TLTrident Lifeline543616Quarterly results

Board approves H1 FY27 results, declares first interim dividend of Rs. 0.50 per share

Board approved unaudited standalone and consolidated results for the half year ended 30 September 2026 and declared a first interim dividend for FY 2026-27 of Rs. 0.50 (Fifty Paise) per share, record date Friday, October 30, 2026.

By ScoutQuest · Mon 26 Oct 2026, 11:13 PM IST · 2 min read

Standalone Revenue from Operations (H1, INR in Lacs)

5,956.91

Standalone Net Profit for the Period (H1, INR in Lacs)

1,159.58

First Interim Dividend FY 2026-27 (per share)

Rs. 0.50 (Fifty Paise) per share, record date Friday, October 30, 2026

What the board decided

The board met on 26 October 2026 and approved the unaudited standalone and consolidated financial results for the half year ended 30 September 2026. It also declared the first interim dividend for FY 2026-27 and took note of compliances made during the quarter ended September 30, 2026.

Dividend

• First interim dividend for FY 2026-27: Rs. 0.50 (Fifty Paise) per share
• Record date: Friday, October 30, 2026

The record date decides which shareholders are entitled to receive the dividend.

Auditor's review

The results carry limited review reports from A Bafna & Associates, Chartered Accountants. Their conclusion is that nothing has come to their attention that causes them to believe the statements contain any material misstatement. A limited review is a lighter check than a full audit.

Half year numbers (standalone, unaudited, half year ended 30 September 2026)

• Revenue from operations: 5,956.91 (INR in Lacs), against 4,625.86 in the half year ended 30 September 2025
• Net Profit for the period: 1,159.58 (INR in Lacs), against 841.71
• Basic and diluted earnings per share (not annualised): 9.70

These are standalone figures, so they cover the parent company only.

Quarter numbers (standalone, unaudited, quarter ended 30 September 2026)

• Revenue from operations: 3,272.68 (INR in Lacs)
• Net Profit for the period: 657.83 (INR in Lacs)

Consolidated view

The consolidated statement was also approved and reviewed. The review report lists the parent and the subsidiaries whose results are included: TNS Pharma Private Limited, TLL Parenterals Limited, Trident Mediquip Limited, TLL Elements Private Limited and TLL Wellness Limited (formerly TLL Herbal Limited).

How a retail investor can read this

• Two things happened at the meeting: the half-year numbers were approved, and a cash dividend was declared.
• Revenue from operations and Net Profit for the period are the printed line items; the figures quoted are standalone, so they leave out the subsidiaries.
• Earnings per share is marked not annualised, so it reflects the half year rather than a full-year run rate.
• The dividend is Rs. 0.50 per share, going to shareholders on record as of Friday, October 30, 2026.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev